Results for "Quercetin Senolytic" in Cancer

20 articles

New Senolytic Drugs Force Cancer's Zombie Cells to Self-Destruct
Cancer Research

New Senolytic Drugs Force Cancer's Zombie Cells to Self-Destruct

Scientists found drugs that kill senescent 'zombie cells' by blocking their key survival protein, shrinking tumors in mice.

Press Release
May 13, 2026 0
Not All Zombie Cells Are Bad — Precision Senolytic Therapy Is the Future of Anti-Aging
Cancer Research

Not All Zombie Cells Are Bad — Precision Senolytic Therapy Is the Future of Anti-Aging

New research reveals senescent cells have both harmful and protective roles, pushing anti-aging science toward targeted removal strategies.

Press Release
May 22, 2026 0
DNA Therapy Slashes Bad Cholesterol by 50% Without Statin Side Effects
Cancer Research

DNA Therapy Slashes Bad Cholesterol by 50% Without Statin Side Effects

A new DNA-based treatment blocks the PCSK9 protein, cutting LDL cholesterol by nearly 50% while avoiding common statin side effects.

Press Release
May 2, 2026 0
New Molecule UNI418 Disables Cancer DNA Repair to Restore Drug Sensitivity
Cancer Research

New Molecule UNI418 Disables Cancer DNA Repair to Restore Drug Sensitivity

A small molecule called UNI418 shuts down cancer cells' DNA repair machinery, making drug-resistant tumors vulnerable to treatment again.

Press Release
Jun 11, 2026 0
Mirror Molecule Starves Cancer Cells While Sparing Healthy Tissue
Cancer Research

Mirror Molecule Starves Cancer Cells While Sparing Healthy Tissue

Scientists discover D-cysteine selectively targets cancer cells by disrupting their energy production without harming normal cells.

Press Release
Mar 28, 2026 1
FDA Drug AMD3100 Unlocks Immune Attack on Rare Liver Cancer in Young Adults
Cancer Research

FDA Drug AMD3100 Unlocks Immune Attack on Rare Liver Cancer in Young Adults

Researchers discovered why fibrolamellar carcinoma resists immunotherapy and found an existing drug can free trapped T cells to fight it.

Press Release
Jun 26, 2026 0
New Compounds Force Pancreatic Cancer Cells to Self-Destruct by Overloading Their Own Signals
Cancer Research

New Compounds Force Pancreatic Cancer Cells to Self-Destruct by Overloading Their Own Signals

Experimental PCAI compounds blocked over 90% of pancreatic cancer cell migration and triggered self-destruction by hyperactivating tumor growth pathways.

Press Release
Jun 30, 2026 0
Cholesterol Drug Evolocumab Cuts First Heart Attack Risk by 31% in Diabetics
Cancer Research

Cholesterol Drug Evolocumab Cuts First Heart Attack Risk by 31% in Diabetics

New study shows PCSK9 inhibitor prevents cardiovascular events in high-risk diabetes patients without existing heart disease.

Press Release
Apr 6, 2026 0
Hepatitis C Drug Shows Promise Against Deadly Hepatitis E Virus
Cancer Research

Hepatitis C Drug Shows Promise Against Deadly Hepatitis E Virus

Bemnifosbuvir blocks hepatitis E replication in lab tests, offering hope for treating a virus that kills 70,000 people annually.

Press Release
Apr 7, 2026 0
UCLA Finds Hidden Weakness in Deadly Small Cell Cancers That Could Unlock New Treatments
Cancer Research

UCLA Finds Hidden Weakness in Deadly Small Cell Cancers That Could Unlock New Treatments

A UCLA study found that aggressive small cell cancers lacking the RB gene depend on protein E2F3 to survive — blocking it stopped tumor growth in lab models.

Press Release
Jul 5, 2026 0
Supercharged Natural Killer Cells Crack Tumor Defenses in Aggressive Cancers
Cancer Research

Supercharged Natural Killer Cells Crack Tumor Defenses in Aggressive Cancers

McGill scientists boosted NK cell cancer-killing power using reversible drug treatment, targeting leukemia, glioblastoma, and triple-negative breast cancer.

Press Release
May 25, 2026 0
Single Protein Knockout Keeps Cancer-Fighting CAR T Cells Alive Longer
Cancer Research

Single Protein Knockout Keeps Cancer-Fighting CAR T Cells Alive Longer

Disabling the NFIL3 protein prevents CAR T cell exhaustion, boosting tumor-fighting power in animal models of hard-to-treat cancers.

Press Release
Jun 3, 2026 0
Whole Plant Foods Target All 10 Cancer Hallmarks Better Than Single Drugs
Cancer Research

Whole Plant Foods Target All 10 Cancer Hallmarks Better Than Single Drugs

Plant compounds naturally target multiple cancer pathways simultaneously, offering advantages over pharmaceutical approaches.

Press Release
Mar 28, 2026 1
Scientists discover bone receptor that could prevent osteoporosis for life
Cancer Research

Scientists discover bone receptor that could prevent osteoporosis for life

New compound AP503 activates GPR133 receptor to rebuild bone density in mice, offering hope for millions with osteoporosis.

Press Release
Apr 7, 2026 0
Oxford Calculator Shows 98% of Statin Candidates Face Low Muscle Risk
Cancer Research

Oxford Calculator Shows 98% of Statin Candidates Face Low Muscle Risk

A new Oxford tool using 5.6 million patient records shows serious statin muscle side effects are rare, yet 60% of eligible patients skip the drug.

Press Release
Jul 3, 2026 0
New Drug Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer Breakthrough
Cancer Research

New Drug Daraxonrasib Nearly Doubles Survival in Pancreatic Cancer Breakthrough

A once-undruggable cancer driver has finally been targeted, cutting death risk by 60% in a landmark 500-patient trial.

Press Release
Jun 5, 2026 0
New Cancer Treatment Eliminates Tumors Throughout Body After Single Injection
Cancer Research

New Cancer Treatment Eliminates Tumors Throughout Body After Single Injection

Redesigned immunotherapy injected into one tumor triggered complete cancer remission in 2 of 12 patients, with untreated tumors also disappearing.

Press Release
Mar 28, 2026 3
Scientists Discover Hidden Immune Brake SLAMF6 That Lets Cancer Escape Treatment
Cancer Research

Scientists Discover Hidden Immune Brake SLAMF6 That Lets Cancer Escape Treatment

A newly identified molecule called SLAMF6 exhausts cancer-fighting T cells from within — and blocking it may revive failed immunotherapies.

Press Release
Jun 11, 2026 0
AstraZeneca's In Vivo CAR-T Shows Promise Against Multiple Myeloma Despite Safety Concerns
Cancer Research

AstraZeneca's In Vivo CAR-T Shows Promise Against Multiple Myeloma Despite Safety Concerns

New trial data reveals AstraZeneca's experimental in vivo CAR-T therapy showed early responses in multiple myeloma patients but resulted in one death.

Press Release
Mar 28, 2026 1
Cancer's Immune Escape Trick Backfires by Opening a New Attack Route
Cancer Research

Cancer's Immune Escape Trick Backfires by Opening a New Attack Route

When tumors hide from killer T cells, they accidentally expose themselves to helper T cells that trigger a lethal iron-driven cell death process.

Press Release
Jun 5, 2026 0
Page 1 of 2Next